Contego Medical, Inc., headquartered in the United States, is a pioneering force in the medical device industry, specialising in innovative solutions for vascular access and interventional procedures. Founded in 2013, the company has rapidly established itself as a leader in the development of advanced technologies that enhance patient safety and procedural efficiency. With a focus on products such as the Contego® Vascular Access System, Contego Medical stands out for its unique approach to minimising complications associated with traditional vascular access methods. The company operates primarily in North America, with a growing presence in international markets, and has achieved significant milestones in product development and regulatory approvals. Recognised for its commitment to quality and innovation, Contego Medical continues to shape the future of medical devices, ensuring better outcomes for patients and healthcare providers alike.
How does Contego Medical, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Contego Medical, Inc.'s score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Contego Medical, Inc., headquartered in the US, currently does not have any reported carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that Contego Medical may still be in the early stages of developing its climate commitments or reporting frameworks. In the context of the medical device industry, many companies are increasingly focusing on sustainability and carbon reduction initiatives. However, without specific emissions data or targets, it is challenging to assess Contego Medical's position relative to industry standards. As the company progresses, it may consider establishing measurable goals aligned with global climate initiatives to enhance its environmental impact and transparency.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Contego Medical, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.